Literature DB >> 11303203

The risks of spontaneous preterm delivery and perinatal mortality in relation to size at birth according to fetal versus neonatal growth standards.

F Lackman1, V Capewell, B Richardson, O daSilva, R Gagnon.   

Abstract

OBJECTIVE: The aim of this study was to test the null hypothesis that size at birth relative to fetal or neonatal growth standards is not a significant variable related to the risk of spontaneous preterm delivery. STUDY
DESIGN: This was a hospital-based cohort study of consecutive births at a tertiary care perinatal center from January 1, 1985, to December 31, 1996. A total of 37,377 pregnancies met the following inclusion criteria: (1) singleton gestation, (2) 25 to 40 weeks' gestation, and (3) no anomalies. Neonates were divided into 5 birth weight categories according to either fetal (uncorrected for sex) or neonatal (corrected for sex) growth standards, as follows: (1) intrauterine growth restriction, birth weight <3rd percentile; (2) borderline intrauterine growth restriction, birth weight > or = 3rd percentile and <10th percentile; (3) appropriate for gestational age, birth weight from 10th percentile through 90th percentile; (4) borderline large for gestational age, birth weight >90th percentile but < or = 97th percentile, and (5) large for gestational age, birth weight >97th percentile. Logistic regression analysis was used to estimate the independent effect of birth weight category on the risk of preterm delivery after spontaneous onset of labor, with the appropriate-for-gestational-age group serving as a reference.
RESULTS: When fetal growth standards were applied, there was a significant increase in the risk of spontaneous preterm delivery when birth weight was outside the appropriate-for-gestational-age range (odds ratios of 2.5, 1.4, 1.2, and 1.9 for intrauterine growth restriction, borderline intrauterine growth restriction, borderline large-for-gestational age, and large-for-gestational-age groups, respectively). In contrast, when neonatal growth standards were applied, the risks of spontaneous preterm delivery in intrauterine growth restriction, borderline intrauterine growth restriction, and large-for-gestational-age groups were significantly lower (odds ratios of 0.5, 0.7, and 0.7 for intrauterine growth restriction, borderline intrauterine growth restriction, and large-for-gestational-age groups, respectively) because of an underestimation in the number of fetuses with abnormal size at birth delivered prematurely. With both fetal and neonatal growth standards there was a 5-to 6-fold greater risk of perinatal death for both preterm and term fetuses with intrauterine growth restriction.
CONCLUSION: Fetal growth standards are more appropriate in predicting the impact of birth weight category on the risk of spontaneous preterm delivery than are neonatal growth standards. When fetal standards are applied, the risks of preterm birth in both extreme abnormal birth weight categories (intrauterine growth restriction and large for gestational age) are 2- to 3-fold greater than the risk among appropriate-for-gestational-age infants.

Entities:  

Mesh:

Year:  2001        PMID: 11303203     DOI: 10.1067/mob.2001.111719

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  42 in total

1.  Decreased placental amino acid transport and intrauterine growth restriction: which is the chicken and which is the egg?

Authors:  Peter W Nathanielsz
Journal:  J Physiol       Date:  2006-09-14       Impact factor: 5.182

2.  The significance of endothelin in platelet-activating factor-induced fetal growth restriction.

Authors:  Mark G Neerhof; Saira Khan; Sylvia Synowiec; Xiao-Wu Qu; Larry G Thaete
Journal:  Reprod Sci       Date:  2012-04-25       Impact factor: 3.060

3.  Estimated fetal weights versus birth weights: should the reference intrauterine growth curves based on birth weights be retired?

Authors:  Richard A Ehrenkranz
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-05       Impact factor: 5.747

4.  Site-specific methylation of placental HSD11B2 gene promoter is related to intrauterine growth restriction.

Authors:  Yan Zhao; Xia Gong; Li Chen; Luxi Li; Yuan Liang; ShangQin Chen; Yunhui Zhang
Journal:  Eur J Hum Genet       Date:  2013-10-16       Impact factor: 4.246

5.  Gestational exposure to elevated testosterone levels induces hypertension via heightened vascular angiotensin II type 1 receptor signaling in rats.

Authors:  Vijayakumar Chinnathambi; Amar S More; Gary D Hankins; Chandra Yallampalli; Kunju Sathishkumar
Journal:  Biol Reprod       Date:  2014-05-22       Impact factor: 4.285

6.  Accelerated postnatal head growth follows preterm birth.

Authors:  J Cockerill; S Uthaya; C J Doré; N Modi
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-01-12       Impact factor: 5.747

7.  Banking placental tissue: an optimized collection procedure for genome-wide analysis of nucleic acids.

Authors:  L M Wolfe; R D Thiagarajan; F Boscolo; V Taché; R L Coleman; J Kim; W K Kwan; J F Loring; M Parast; L C Laurent
Journal:  Placenta       Date:  2014-06-06       Impact factor: 3.481

8.  Racial residential segregation and low birth weight in Michigan's metropolitan areas.

Authors:  Michelle Precourt Debbink; Michael D M Bader
Journal:  Am J Public Health       Date:  2011-07-21       Impact factor: 9.308

9.  Early rapid growth, early birth: accelerated fetal growth and spontaneous late preterm birth.

Authors:  Michelle Lampl; Juan Pedro Kusanovic; Offer Erez; Jimmy Espinoza; Francesca Gotsch; Luis Goncalves; Sonia Hassan; Ricardo Gomez; Jyh Kae Nien; Edward A Frongillo; Roberto Romero
Journal:  Am J Hum Biol       Date:  2009 Mar-Apr       Impact factor: 1.937

10.  Hypoglycemia and the origin of hypoxia-induced reduction in human fetal growth.

Authors:  Stacy Zamudio; Tatiana Torricos; Ewa Fik; Maria Oyala; Lourdes Echalar; Janet Pullockaran; Emily Tutino; Brittney Martin; Sonia Belliappa; Elfride Balanza; Nicholas P Illsley
Journal:  PLoS One       Date:  2010-01-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.